PL3223795T3 - Formulacja do skutecznego dostarczania tokotrienolu - Google Patents

Formulacja do skutecznego dostarczania tokotrienolu

Info

Publication number
PL3223795T3
PL3223795T3 PL15863611T PL15863611T PL3223795T3 PL 3223795 T3 PL3223795 T3 PL 3223795T3 PL 15863611 T PL15863611 T PL 15863611T PL 15863611 T PL15863611 T PL 15863611T PL 3223795 T3 PL3223795 T3 PL 3223795T3
Authority
PL
Poland
Prior art keywords
formulation
effective
tocotrienol
delivery
tocotrienol delivery
Prior art date
Application number
PL15863611T
Other languages
English (en)
Inventor
Chee Wai FONG
Yee Wei UNG
Jordan Todorov Petkov
Original Assignee
Kl-Kepong Oleomas Sdn Bhd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kl-Kepong Oleomas Sdn Bhd filed Critical Kl-Kepong Oleomas Sdn Bhd
Publication of PL3223795T3 publication Critical patent/PL3223795T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4875Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL15863611T 2014-11-25 2015-11-19 Formulacja do skutecznego dostarczania tokotrienolu PL3223795T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MYPI2014703502A MY182652A (en) 2014-11-25 2014-11-25 Formulation for effective tocotrienol delivery
EP15863611.8A EP3223795B1 (en) 2014-11-25 2015-11-19 Formulation for effective tocotrienol delivery
PCT/MY2015/050143 WO2016085325A1 (en) 2014-11-25 2015-11-19 Formulation for effective tocotrienol delivery

Publications (1)

Publication Number Publication Date
PL3223795T3 true PL3223795T3 (pl) 2022-02-14

Family

ID=56074748

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15863611T PL3223795T3 (pl) 2014-11-25 2015-11-19 Formulacja do skutecznego dostarczania tokotrienolu

Country Status (17)

Country Link
US (2) US10493055B2 (pl)
EP (1) EP3223795B1 (pl)
JP (1) JP6675413B2 (pl)
KR (1) KR102414627B1 (pl)
CN (1) CN106999428B (pl)
AU (1) AU2015354848C1 (pl)
CA (1) CA2968523C (pl)
DK (1) DK3223795T3 (pl)
ES (1) ES2898724T3 (pl)
HU (1) HUE056584T2 (pl)
MY (1) MY182652A (pl)
NZ (1) NZ731986A (pl)
PH (1) PH12017500943B1 (pl)
PL (1) PL3223795T3 (pl)
PT (1) PT3223795T (pl)
SG (1) SG11201704137RA (pl)
WO (1) WO2016085325A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI799599B (zh) * 2019-06-06 2023-04-21 華納國際生物科技股份有限公司 醫藥或保健品自乳化固體分散組成物
MY203355A (en) * 2021-12-27 2024-06-25 Sd Guthrie Intellectual Property Sdn Bhd Self-emulsifying composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7012460A (pl) * 1970-08-22 1972-02-24
CN1045049C (zh) * 1994-10-15 1999-09-15 吴桂荣 一种红花油乳液及其制备方法
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
SG97918A1 (en) * 2000-06-08 2003-08-20 Hovid Sdn Bhd A novel drug delivery system: formulation for fat-soluble drugs
US6596306B1 (en) * 2000-07-07 2003-07-22 David Ho Sue San Ho Drug delivery system:formulation for fat-soluble drugs
DE10036871A1 (de) * 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
JP4316185B2 (ja) * 2002-04-04 2009-08-19 三菱化学株式会社 トコフェロール類及びトコトリエノール類の分離方法
US20040005339A1 (en) * 2002-06-28 2004-01-08 Shojaei Amir H. Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
US8489388B2 (en) * 2008-11-10 2013-07-16 Apple Inc. Data detection
WO2012033478A1 (en) * 2010-09-07 2012-03-15 Murty Pharmaceuticals, Inc. An improved oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
JP2013060551A (ja) 2011-09-14 2013-04-04 Klueber Lubrication Muenchen Kg 潤滑グリース組成物
EP2758969B1 (en) * 2011-09-23 2015-11-04 E. I. du Pont de Nemours and Company Dielectric fluids comprising polyol esters, methods for preparing mixtures of polyol esters, and electrical apparatuses comprising polyol ester dielectric fluids
US10874635B2 (en) * 2011-10-21 2020-12-29 First Tech International Limited Tocotrienol compositions

Also Published As

Publication number Publication date
PH12017500943A1 (en) 2017-11-20
PH12017500943B1 (en) 2023-03-08
US10478417B2 (en) 2019-11-19
EP3223795B1 (en) 2021-09-01
DK3223795T3 (da) 2021-11-22
HUE056584T2 (hu) 2022-02-28
AU2015354848C1 (en) 2019-07-11
SG11201704137RA (en) 2017-06-29
CN106999428B (zh) 2020-10-20
JP6675413B2 (ja) 2020-04-01
CA2968523C (en) 2023-10-03
AU2015354848A1 (en) 2017-06-08
NZ731986A (en) 2018-08-31
US20190111021A1 (en) 2019-04-18
KR20170088936A (ko) 2017-08-02
EP3223795A1 (en) 2017-10-04
JP2017535611A (ja) 2017-11-30
MY182652A (en) 2021-01-27
US10493055B2 (en) 2019-12-03
KR102414627B1 (ko) 2022-06-30
EP3223795A4 (en) 2018-07-25
CN106999428A (zh) 2017-08-01
PT3223795T (pt) 2021-11-22
AU2015354848B2 (en) 2018-09-13
BR112017010912A2 (pt) 2017-12-26
WO2016085325A1 (en) 2016-06-02
ES2898724T3 (es) 2022-03-08
CA2968523A1 (en) 2016-06-02
US20170326101A1 (en) 2017-11-16

Similar Documents

Publication Publication Date Title
LT3236943T (lt) Kompozicija, skirta vaistų pristatymui per klubinę ir tiesiąją žarną
IL246186B (en) Pharmaceutical preparations containing azd9291
GB201407934D0 (en) Formulation
IL250343B (en) A preparation containing factor viii
IL247106B (en) Material delivery system
GB201407384D0 (en) Formulation
IL248835B (en) A preparation of ciritinib
GB201402448D0 (en) Novel formulation
ZA201605787B (en) Formulations for small intestinal delivery
GB201511301D0 (en) Formulation
SG11201704137RA (en) Formulation for effective tocotrienol delivery
IL251362A0 (en) formulation
GB201514902D0 (en) Formulations for transmucosal delivery
GB201514906D0 (en) Formulations for transmucosal delivery
EP3206741C0 (en) DEVICES FOR ADMINISTERING THERAPEUTIC SUBSTANCES
GB201416536D0 (en) Formulation
GB201416274D0 (en) Formulation
GB201412754D0 (en) Formulation
GB201404773D0 (en) Formulation
GB201407741D0 (en) Novel drug formulation
GB201400951D0 (en) Novel drug formulation
GB201405197D0 (en) Delivery suite- whelping system